EUVD-2019-4688

Malware in sbrugna...

CVE-2019-13157

nsGreen.dll in Naver Vaccine 2.1.4 allows remote attackers to overwrite arbitary files via directory traversal sequences in a filename within nsz archive...

Naver Vaccine Path Traversal Vulnerability

Naver Vaccine is a suite of computer security protection software from the Korean company Naver. Naver Vaccine suffers from a path traversal vulnerability. The vulnerability stems from a failure of a network system or product to properly filter for specific elements in a resource or file path. An...

CVE-2019-13157

nsGreen.dll in Naver Vaccine 2.1.4 allows remote attackers to overwrite arbitary files via directory traversal sequences in a filename within nsz archive...

CVE-2019-13157

nsGreen.dll in Naver Vaccine 2.1.4 allows remote attackers to overwrite arbitary files via directory traversal sequences in a filename within nsz archive...

Directory traversal

nsGreen.dll in Naver Vaccine 2.1.4 allows remote attackers to overwrite arbitary files via directory traversal sequences in a filename within nsz archive...

CVE-2019-13157

nsGreen.dll in Naver Vaccine 2.1.4 allows remote attackers to overwrite arbitary files via directory traversal sequences in a filename within nsz archive...

CVE-2019-13157

CVE-2019-13157 concerns the Naver Vaccine product, specifically the nsGreen.dll in version 2.1.4. The issue is a path traversal vulnerability in archives (nsz) that allows remote attackers to overwrite arbitrary files by manipulating directory traversal sequences in a filename contained within th...

CVE-2019-13157

nsGreen.dll in Naver Vaccine 2.1.4 allows remote attackers to overwrite arbitary files via directory traversal sequences in a filename within nsz archive...